Europe Infection Control Market – Industry Trends and Forecast to 2030

Europe Infection Control Market Analysis and Size

According to the data provided by the WHO, Acute Respiratory Diseases (ARDs) are one of the main reasons for the high mortality rates experienced. Every year, ARDs are responsible for over 4.0 million deaths. The data given above demonstrate the critical necessity for strict prevention and control. The majority of all hospital-acquired infections are caused by illnesses such as pneumonia and infections of the bloodstream, urinary system, surgical site, and MRSA. The infections may be transmitted directly or indirectly from one person to another through contaminated or unsterilized surgical or medical equipment used to treat a patient or from a contaminated environment in a healthcare facility.

Data Bridge Market Research analyses that the infection control market which is USD 8,934.67 million in 2022, is expected to reach USD 26,580.03 million by 2030, at a CAGR of 14.60% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Europe Infection Control Market Scope and Segmentation      

Market Definition

The process of infection control is used in the healthcare sector to stop or prevent the spread of infections. The activity of infection control involves getting rid of bacteria from various surfaces and things. This procedure makes it possible for people to avoid disease transmission and pollution. A scientific strategy called infection control is intended to stop the harm infections can do to patients and healthcare professionals. In all healthcare settings, infection control is necessary to stop the spread of infectious diseases. It can be described as a set of generally accepted suggestions used to decrease the danger of infectious agents being transmitted by environmental or bodily fluids.

Europe Infection Control Market Dynamics

Drivers

• Rising government organizations

In the forecast period, the market is expected to develop as a result of the rising involvement of governmental organizations in the publication of recommendations to spread knowledge about practical preventative strategies. For instance, the World Health Organization (WHO) has issued guidelines in healthcare for the prevention and control of pandemic and epidemic-prone acute respiratory diseases. The guidelines cover everything from standard precautions such as hand hygiene and the use of personal protective equipment to disinfection and sterilization procedures.

• Increase in hospitalization

According to a WHO guidelines on HAI prevention, the increase in hospitalization duration with surgical infections was found to be approximately eight days. These extended stays are expected to contribute significantly to the overall costs incurred during the hospitalization, raising the clinical urgency for implementing infection prevention measures. It is assumed that a prolonged hospital stay is also not cost effective for hospitals and healthcare payers due to the excessive use of resources to treat the acquired infection. These additional costs are primarily caused by increased drug usage, additional diagnostic studies, and laboratory equipment, resulting in a resource allocation imbalance.

Opportunities

• Increasing use of e-beam sterilization

Beta radiation, often known as electron-beam irradiation, is frequently used to sterilize medical equipment and pharmaceutical packaging. It works by continuously passing electrons through the items being sterilized. The benefit of this treatment is that it offers quick-turn terminal sterilization using straightforward, hygienic on/off technology. The product can be distributed right away because no residuals or radioactive or carcinogenic gas sources are required. The market for infection control is anticipated to have considerable expansion during the forecast period as a result of the expanding applications of e-beam sterilization and its adoption among various end-user sectors.

Restraints/Challenges

• Concerns about the safety of the processed instruments

Concerns about the safety of the processed instruments used in surgeries are extremely dangerous for patients as well as healthcare workers or professionals, resulting in the spread of infection and acting as a restraint factor hampered the growth of the infection control market.

This infection control market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the infection control market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In 2020, Getinge AB launched superfast indicators to further ensure patient safety. The new Superfast 20 indicators are ISO 11138 compliant and compatible with most steam and hydrogen peroxide process sterilizers. This product launch will assist the company in increasing its market share in the global patient safety market.
• In 2019, Cardinal Health announced the acquisition of mscripts, a company that provides patient adherence and engagement solutions through an innovative, user-friendly mobile and web-based health management platform. This will assist the company in promoting patient adherence to prescriptions and improving overall health outcomes.

Europe Infection Control Market Scope

The infection control market is segmented on the basis of product, application, distribution channel and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Sterilization
• Cleaning and Disinfection
• Personal Protective Barriers
• Endoscope Reprocessing
• Anti-Microbial Surfaces
• Other Infection Control

 Application

• Surgical Instruments
• Endoscopes
• Ultrasound Probes
• Others

 Distribution Channel

• Direct Tender
• Retail Sales
• Third Party Distributors

End User

• Hospitals
• Clinics
• Medical Device Companies
• Pharmaceutical and Biotechnology Companies
• Laboratories
• Others

Infection Control Market Regional Analysis/Insights

The infection control market is analyzed and market size insights and trends are provided by country, product, application, distribution channel and end user as referenced above.

The countries covered in the infection control market report are Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe.

France is expected to grow with the most promising growth rate in the forecast period of 2023 to 2030 due to rising healthcare spending and an increase in infectious disease prevalence in the area.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The infection control market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for infection control market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the infection control market. The data is available for historic period 2011-2021.

Competitive Landscape and Infection Control Market Share Analysis

The infection control market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to infection control market.

Some of the major players operating in the infection control market are:

• STERIS plc (U.S.)
• Sotera Health Company (U.S.)
• Getinge AB (Sweden)
• Advanced Sterilization Products (ASP) (U.S.)
• Ecolab Inc. (U.S.)
• 3M (U.S.)
• MATACHANA GROUP (Spain)
• MMM Group (Germany)
• Belimed AG (Switzerland)
• Reckitt Benckiser (U.K.)
• Metrex Research LLC (U.K.)
• Miele Group (Germany)
• Pal International (U.K.)
• MELAG Medizintechnik GmbH & Co. KG (Germany)
• Contec, Inc. (U.S.)
• MEDALKAN (Greece)
• Systec GmbH (Germany)
• C.B.M. S.r.l. Medical Equipment (Italy)
• Continental Equipment Company (U.S.)
• BGS Beta-Gamma-Service GmbH & Co. KG (Germany)

SKU-55596